TANG CAPITAL MANAGEMENT LLC Q1 2019 Filing
Filed May 15, 2019
Portfolio Value
$542.7B
Holdings
9
Report Date
Q1 2019
Filing Type
13F-HR
All Holdings (9 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —ODONATE THERAPEUTICS INC | 13,086,038 | $289.3B | 53.31% | |
| 2 | HRTXHERON THERAPEUTICS INC | 5,744,096 | $140.4B | 25.87% | |
| 3 | RCKTROCKET PHARMACEUTICALS INC | 2,965,485 | $52.0B | 9.58% | |
| 4 | —LA JOLLA PHARMACEUTICAL CO | 4,938,893 | $31.8B | 5.85% | |
| 5 | PBYIPUMA BIOTECHNOLOGY INC | 349,400 | $13.6B | 2.50% | |
| 6 | CELGCELGENE CORP | 111,844 | $10.6B | 1.94% | |
| 7 | PRTAPROTHENA CORP PLC | 323,823 | $3.9B | 0.72% | |
| 8 | —OPHTHOTECH CORP | 600,000 | $846.0M | 0.16% | |
| 9 | EQEQUILLIUM INC | 47,343 | $379.0M | 0.07% |